Transcriptomics

Dataset Information

0

Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19


ABSTRACT: While critical for host defense, innate immune cells are also pathologic drivers of acute respiratory distress syndrome (ARDS). Innate immune dynamics during COVID-19 ARDS, compared to ARDS from other respiratory pathogens, is unclear. Moreover, mechanisms underlying beneficial effects of dexamethasone during severe COVID-19 remain elusive. Using scRNA-seq and plasma proteomics, we discovered that compared to bacterial ARDS, COVID-19 was associated with expansion of distinct neutrophil states characterized by interferon (IFN) and prostaglandin (PG) signalling. Dexamethasone during severe COVID-19 depleted circulating neutrophils, altered IFNactive neutrophils, downregulated interferon-stimulated gene, and activated IL1R2+ve neutrophils. Dexamethasone also expanded immunosuppressive immature neutrophils and remodeled cellular interactions by changing neutrophils from information receivers into information providers. Male patients had higher proportions of IFNactive neutrophils, preferential steroid-induced immature neutrophil expansion, and possibly different effects on outcome. Our single-cell atlas (www.biernaskielab.ca/COVID_neutrophil) defines COVID-19-enriched neutrophil states and molecular mechanisms of dexamethasone action to develop targeted immunotherapies for severe COVID-19.

ORGANISM(S): Homo sapiens

PROVIDER: GSE157789 | GEO | 2021/10/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-10-05 | PXD028429 | Pride
2021-02-03 | PXD023834 | Pride
2024-07-23 | GSE272381 | GEO
2022-11-16 | GSE186267 | GEO
| PRJNA662785 | ENA
2023-02-13 | GSE213313 | GEO
2024-07-29 | GSE273149 | GEO
2022-03-01 | E-MTAB-10970 | biostudies-arrayexpress
2022-08-28 | GSE159585 | GEO
2021-07-20 | GSE154311 | GEO